Y-Intercept (HK)’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Y-Intercept (HK)’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-47,469	Closed	-$85.9K	–	1781
2023 Q2	$85.9K	Buy	+47,469	New	+$86.8K	0.01%	1132

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Y-Intercept (HK)'s PRDS Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 47,469 shares — an estimated $85.9K sold.

Y-Intercept (HK) first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $85.9K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Y-Intercept (HK) reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 47,469 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $85.9K.
Y-Intercept (HK) first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Y-Intercept (HK)'s Pardes Biosciences, Inc. Common Stock position peaked at $85.9K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.